1 / 15

Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W

This study examines the impact of the pharmaceutical industry on medical guidelines using two examples from Germany. It highlights potential conflicts of interest and their implications in healthcare decision-making.

evonp
Download Presentation

Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  2. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  3. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  4. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  5. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  6. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  7. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  8. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  9. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  10. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  11. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  12. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  13. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  14. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

  15. Schott, G; Dünnweber, C; Mühlbauer, B; Niebling, W; Pachl, H; Ludwig, W DoesthePharmaceuticalIndustryInfluenceGuidelines? TwoExamplesFrom Germany DtschArzteblInt 2013; 110(35-36): 575-83; DOI: 10.3238/arztebl.2013.0575

More Related